[Clinical research progress of stem cell therapy for decompensated cirrhosis and liver failure]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang YH +4 more
europepmc +1 more source
[Two-sample Mendelian randomization analysis for the causal relationship between 91 circulating inflammatory proteins and liver cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLi M +5 more
europepmc +1 more source
[Research progress of tolvaptan in the treatment of refractory ascites in cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhang QQ, Chen Y, Chen YX, Yang L.
europepmc +1 more source
[Clinical treatment controversies and progress in liver cirrhosis: an evidence-based medicine perspective from managing portal hypertension to preventing complications]. [PDF]
Zhonghua Gan Zang Bing Za ZhiYang YF, Wang JJ, Chen GW, Ge QC, Lu LG.
europepmc +1 more source
[New targets for the prevention and treatment of cirrhotic portal vein thrombosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang YW, Ding HG.
europepmc +1 more source
[A case of Castleman's disease misdiagnosed as cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiGao YF +6 more
europepmc +1 more source
[Pay attention to the diagnosis and treatment of "easily neglected" complications in liver cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiXu JH, Yu YY, Xu XY.
europepmc +1 more source
[Tenofovir amibufenamide treatment in a case of hepatitis B virus-related decompensated liver cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLi YP, Gou GE, Dang SS.
europepmc +1 more source
[Real-world study of tenofovir amibufenamide in the treatment of patients with hepatitis B cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHan Y +5 more
europepmc +1 more source
[Tenofovir amibufenamide inhibiting low-level viremia and delaying the progression of liver cirrhosis: a case report]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhao CY, Nie CF, Zhao ZH.
europepmc +1 more source